Evidence map›Paper›PMID 24732313›Full record

ArticleHuman vaccines & immunotherapeutics2014

Induction of dendritic cell maturation in the skin microenvironment by soluble factors derived from colon carcinoma.

Jelle J Lindenberg, Rieneke van de Ven, Dinja Oosterhoff, Claudia C Sombroek, Sinéad M Lougheed, Anita G M Stam, Hans J P M Koenen, Alfons J M van den Eertwegh, Rik J Scheper, Tanja D de Gruijl

Open access · bronzeAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Jelle J LindenbergDepartment of Medical Oncology; VU University medical center; De Boelelaan, Amsterdam, The Netherlands.
Rieneke van de VenDepartment of Medical Oncology; VU University medical center; De Boelelaan, Amsterdam, The Netherlands.
Dinja OosterhoffDepartment of Medical Oncology; VU University medical center; De Boelelaan, Amsterdam, The Netherlands.
Claudia C SombroekDepartment of Pathology; VU University medical center; De Boelelaan, Amsterdam, The Netherlands.
Sinéad M LougheedDepartment of Medical Oncology; VU University medical center; De Boelelaan, Amsterdam, The Netherlands.
Anita G M StamDepartment of Pathology; VU University medical center; De Boelelaan, Amsterdam, The Netherlands.
Hans J P M KoenenLaboratory of Medical Immunology; Department of Laboratory Medicine; Radboud University Nijmegen Medical Centre; Nijmegen, The Netherlands.
Alfons J M van den EertweghDepartment of Medical Oncology; VU University medical center; De Boelelaan, Amsterdam, The Netherlands.
Rik J ScheperDepartment of Pathology; VU University medical center; De Boelelaan, Amsterdam, The Netherlands.
Tanja D de GruijlDepartment of Medical Oncology; VU University medical center; De Boelelaan, Amsterdam, The Netherlands.
Amsterdam UMC Location VUmc · NLState Key Laboratory of Medical Immunology

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autologous tumor cell-based vaccines provide a wide range of tumor antigens and personalized neo-epitopes based on individual tumors' unique antigenic mutanome signatures. However, tumor-derived factors may hamper in situ maturation of dendritic cells (DC) and thus interfere with the generation of effective anti-tumor immunity. As the skin is a preferred site for tumor vaccine delivery, we investigated the influence of primary colon carcinoma-derived soluble factors on the maturation state of migrating DC in a human skin explant model. Primary tumor-derived supernatants (TDSN) enhanced the phenotypic maturation state of skin-emigrated DC, resulting in an increased T-cell stimulatory ability in an allogeneic mixed leukocyte response. In case of monocyte-derived DC a similar TDSN-induced maturation induction was found to entirely depend on cyclooxygenase (COX)-regulated prostaglandins. In contrast, the increase in skin-emigrated DC maturation was completely prostaglandin-independent, as evidenced by the inability of the COX inhibitor indomethacin to abrogate this TDSN-induced effect. Although TDSN conditioning affected a drop in IL-12p70 release by the skin-emigrated DC and induced a predominant Th17/Th22 transcriptional profile in subsequently stimulated T-cells, Th cell subset differentiation, as assessed by intracellular cytokine expression upon polyclonal priming and re-stimulation, was not affected. Comparative analysis of phenotypic and transcriptional profiles suggests that the observed maturational effects in skin-derived DC may have been induced by tumor-derived GM-CSF. In conclusion, soluble factors derived from whole-cell colon tumor vaccines will not negatively impact DC migration and maturation in human skin, but rather induce DC maturation that will facilitate the priming of a poly-functional Th cell response.

Indexed as

AnimalsCarcinomaCell DifferentiationCell LineCell MovementColonic NeoplasmsDendritic CellsImmunologic FactorsMiceSkinImmunologic Factorscolon cancerCOXdendritic cellsGM-CSFprostaglandinskin

Identifiers

PMID24732313
PMCPMC5396241
OpenAlexW2098189973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.